Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 6, Pages 1155-1168
Publisher
Wiley
Online
2015-02-21
DOI
10.1016/j.molonc.2015.02.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Underuse of Trimodality Treatment Affects Survival for Patients With Inflammatory Breast Cancer: An Analysis of Treatment and Survival Trends From the National Cancer Database
- (2014) Natasha M. Rueth et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypes
- (2013) H. Masuda et al. ANNALS OF ONCOLOGY
- Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival
- (2013) F. Bertucci et al. ANNALS OF ONCOLOGY
- The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization
- (2013) Kevin P. Williams et al. CANCER LETTERS
- Risk Factors for Locoregional Failure in Patients With Inflammatory Breast Cancer Treated With Trimodality Therapy
- (2013) Kunal Saigal et al. Clinical Breast Cancer
- Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets
- (2013) S. J. Van Laere et al. CLINICAL CANCER RESEARCH
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages
- (2012) Jonatan Taminau et al. BMC BIOINFORMATICS
- Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
- (2012) Bisrat G. Debeb et al. BREAST CANCER RESEARCH AND TREATMENT
- Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
- (2012) Jennifer L. Allensworth et al. BREAST CANCER RESEARCH AND TREATMENT
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Metal-dithiocarbamate complexes: chemistry and biological activity
- (2012) Graeme Hogarth MINI-REVIEWS IN MEDICINAL CHEMISTRY
- XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells
- (2012) J. L. Allensworth et al. MOLECULAR CANCER THERAPEUTICS
- Zinc Pyrithione Inhibits Yeast Growth through Copper Influx and Inactivation of Iron-Sulfur Proteins
- (2011) Nancy L. Reeder et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells
- (2011) Katherine M. Aird et al. BREAST CANCER RESEARCH AND TREATMENT
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
- (2011) N C Yip et al. BRITISH JOURNAL OF CANCER
- Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer
- (2010) Takayuki Iwamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise
- (2010) H. Kashkar CLINICAL CANCER RESEARCH
- X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells with Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor
- (2010) K. M. Aird et al. MOLECULAR CANCER THERAPEUTICS
- Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells
- (2010) Ann H. Klopp et al. PLoS One
- Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression
- (2010) Ilaria Bellezza et al. Cancers
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
- (2009) Deborah Silvera et al. NATURE CELL BIOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- The use of copper-lowering therapy with tetrathiomolybdate in medicine
- (2008) George J Brewer EXPERT OPINION ON INVESTIGATIONAL DRUGS
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression
- (2008) K. M. Aird et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started